Not Found
On Demand

CGRP Antibody Therapy: A New Frontier in Migraine Treatment

Total Credits: .5 including .5 AOA Category 1-A Credit(s)

Average Rating:
Not yet rated
AOA Category 1-A Credit |  AOMA |  Neurology
Justin Delange, DO
90 Days
AOA Number:
Never expires.


CGRP Antibody Therapy:  A New Frontier in Migraine Treatment
Justin DeLange, DO, FAHS

Learning Objectives

  • Evaluate the importance of migraine preventive therapy
  • Summarize the new CGRP monoclonal antibodies and how they work in migraine
  • Assess the indications for the use of CGRP monoclonal antibodies in migraine

Dr. DeLange discloses he is a consultant for Amgen

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Osteopathic Association (AOA). The Arizona Osteopathic Medical Association (AOMA) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians.

GRIEVANCE POLICY: The AOMA strives to provide continuing medical education programs to fulfill the needs of the attendees and to meet the AOA Uniform Guidelines and AOA Accreditation Requirements. Comments, quest
ions, or complaints should be forwarded to AOMA Executive Director Josephine Zammuto, by calling the AOMA Office at 602-266-6699 or by mail to AOMA, 1951 W. Camelback Rd., Suite 105, Phoenix, AZ 85015, or by email to




Justin Delange, DO Related seminars and products: 2

Flagstaff Medical CEnter

Justin Delange, DO is a board certified neurologist. His practice in Flagstaff, Arizona focuses on general neurology with subspecialty expertise in headache and management of facial pain. He is proficient in peripheral nerve block and Botox injections for headache treatment. His clinical interests involve treating intractable headaches such as chronic migraine; biobehavioral approaches to treatment and advocacy for headaches. Dr. DeLange completed an internal medicine internship and neurology residency at the University of Texas Health Science Center at Houston, where he also serviced as neurology chief resident. He completed a headache medicine fellowship at the Mayo Clinic Department of Neurology, Rochester, Minnesota. He is certified in the subspecialty of Headache Medicine by the United Council for Neurologic Subspecialties. Dr. DeLange is a member of the Arizona Osteopathic Medical Association, Gold Humanism Honor Society, the American Headache Society, and the American Academy of Neurology.

Dr. DeLange has no disclosures. 

Please wait ...

Back to Top